These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32598598)

  • 21. Lispro insulin in people with non-alcoholic liver cirrhosis and type 2 diabetes mellitus.
    Gentile S; Guarino G; Strollo F; Romano M; Genovese S; Masarone M; Ceriello A
    Diabetes Res Clin Pract; 2016 Mar; 113():179-86. PubMed ID: 26803356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The current aspects of the pharmacological correction of hyperglycemia in patients with non-insulin-dependent diabetes mellitus (type 2)].
    Gorbenko NI
    Eksp Klin Farmakol; 1999; 62(5):71-8. PubMed ID: 10572759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice.
    Franko A; Neschen S; Rozman J; Rathkolb B; Aichler M; Feuchtinger A; Brachthäuser L; Neff F; Kovarova M; Wolf E; Fuchs H; Häring HU; Peter A; Hrabě de Angelis M
    Mol Metab; 2017 Mar; 6(3):256-266. PubMed ID: 28271032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diabetes in patients with malignant tumors].
    Lengyel Z; Boér K; Halászlaki C; Németh Z
    Magy Onkol; 2013 Sep; 57(3):177-81. PubMed ID: 24107824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes Mellitus: Management of Gastrointestinal Complications.
    Careyva B; Stello B
    Am Fam Physician; 2016 Dec; 94(12):980-986. PubMed ID: 28075092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tyrosol, a phenolic compound, ameliorates hyperglycemia by regulating key enzymes of carbohydrate metabolism in streptozotocin induced diabetic rats.
    Chandramohan R; Pari L; Rathinam A; Sheikh BA
    Chem Biol Interact; 2015 Mar; 229():44-54. PubMed ID: 25641191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver disease, insulin antagonism and diabetes mellitus.
    Creutzfeldt W; Frerichs H; Kneer P
    Horm Metab Res; 1974; Suppl 4():135-42. PubMed ID: 4423508
    [No Abstract]   [Full Text] [Related]  

  • 28. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Carbohydrate metabolism in liver diseases].
    Mosin VI
    Klin Med (Mosk); 1974 Feb; 52(2):. PubMed ID: 4619410
    [No Abstract]   [Full Text] [Related]  

  • 30. Involvement of liver in diabetes mellitus: herbal remedies.
    Thent ZC; Das S
    Clin Ter; 2014; 165(4):223-30. PubMed ID: 25203338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hepatogenic diabetes--the current concepts of its pathophysiology and therapy].
    Siegel EG; Gallwitz B; Schmidt WE; Fölsch UR
    Dtsch Med Wochenschr; 1999 Dec; 124(50):1530-5. PubMed ID: 10633781
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology.
    Loria P; Marchesini G; Nascimbeni F; Ballestri S; Maurantonio M; Carubbi F; Ratziu V; Lonardo A
    Atherosclerosis; 2014 Jan; 232(1):99-109. PubMed ID: 24401223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucose management, heart failure and transplantation.
    Hamilton DJ; Hendricks SJ; Ihaza E; Rollins JL
    Methodist Debakey Cardiovasc J; 2009; 5(3):12-5. PubMed ID: 20308959
    [No Abstract]   [Full Text] [Related]  

  • 34. Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management.
    Singh MK; Das BK; Choudhary S; Gupta D; Patil UK
    Biomed Pharmacother; 2018 Oct; 106():991-1002. PubMed ID: 30119271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes and liver disease: an ominous association.
    Moscatiello S; Manini R; Marchesini G
    Nutr Metab Cardiovasc Dis; 2007 Jan; 17(1):63-70. PubMed ID: 17164082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes and the liver.
    Padmanabhan M; Mohan V
    J Assoc Physicians India; 2000 Aug; 48(8):824-8. PubMed ID: 11273479
    [No Abstract]   [Full Text] [Related]  

  • 37. Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases.
    Lee HA; Chang Y; Sung PS; Yoon EL; Lee HW; Yoo JJ; Lee YS; An J; Song DS; Cho YY; Kim SU; Kim YJ
    Clin Mol Hepatol; 2022 Jul; 28(3):425-472. PubMed ID: 35850495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antidiabetic agents and renal insufficiency].
    Robles NR; Blanco J
    Nefrologia; 2002; 22(4):325-8. PubMed ID: 12369123
    [No Abstract]   [Full Text] [Related]  

  • 39. [Liver and diabetes mellitus].
    Genes SG
    Ter Arkh; 1976; 48(1):119-28. PubMed ID: 772861
    [No Abstract]   [Full Text] [Related]  

  • 40. Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease.
    Manco M
    J Am Coll Nutr; 2011 Oct; 30(5):295-303. PubMed ID: 22081615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.